학술논문
The SANAD II study of the effectiveness and cost-effectiveness of valproate versus levetiracetam for newly diagnosed generalised and unclassifiable epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial
Document Type
Article
Author
Marson, A.; Sills, G.; Baker, G.A.; Burnside, G.; Tudur-Smith, C.; Williamson, P.; Balabanova, S.; Taylor, C.; Appleton, R.; Smith, D.; Leach, J.P.; Plumpton, C.; Hughes, D.A.; Brown, R.; Hindley, D.; Howell, S.; Maguire, M.; Mohanraj, R.; Smith, P.E.; Lanyon, K.; Manford, M.; Chitre, M.; Parker, A.; Swiderska, N.; Pauling, J.; Hughes, A.; Gupta, R.; Hanif, S.; Awadh, M.; Ragunathan, S.; Cable, N.; Cooper, P.; Hindley, D.; Rakshi, K.; Molloy, S.; Reuber, M.; Ayonrinde, K.; Wilson, M.; Saladi, S.; Gibb, J.; Funston, L.-A.; Cassidy, D.; Boyd, J.; Ratnayaka, M.; Faza, H.; Sadler, M.; Al-Moasseb, H.; Galtrey, C.; Wren, D.; Olabi, A.; Fuller, G.; Khan, M.; Kallappa, C.; Chinthapalli, R.; Aji, B.; Davies, R.; Foster, K.; Hitiris, N.; Hussain, N.; Dowson, S.; Ellison, J.; Sharrack, B.; Gandhi, V.; Powell, R.; Tittensor, P.; Summers, B.; Shashikiran, S.; Dison, P.J.; Samarasekera, S.; McCorry, D.; White, K.; Nithi, K.; Richardson, M.; Page, R.; Deekollu, D.; Slaght, S.; Warriner, S.; Ahmed, M.; Chaudhuri, A.; Chow, G.; Artal, J.; Kucinskiene, D.; Sreenivasa, H.; Velmurugan, S.; Zipitis, C.S.; McLean, B.; Lal, V.; Gregoriou, A.; Maddison, P.; Pickersgill, T.; Anderson, J.; Lawthom, C.; Whitlingum, G.; Rakowicz, W.; Kinton, L.; McLellan, A.; Vora, N.; Zuberi, S.; Kelso, A.; Hughes, I.; Martland, J.; Emsley, H.; de Goede, C.; Singh, R.P.; Moor, C.-C.; Aram, J.; Sakthivel, K.; Nelapatla, S.; Rittey, C.; Pinto, A.; Cock, H.; Richardson, A.; Houston, E.; Cooper, C.; Lawson, G.; Massarano, A.; Burness, C.; Wieshmann, U.; Dey, I.; Sivakumar, P.; Yeung, L.-K.; Smith, P.; Bentur, H.; Heafield, T.; Mathew, A.; Smith, D.; Jauhari, P.
Source
In: The Lancet . (The Lancet, 10 April 2021, 397(10282):1375-1386)
Subject
Language
English
ISSN
1474547X
01406736
01406736